Founded in 2006, MRN is an innovative, market-leading Clinical Trial Support Organization in the field of international community focused clinical trial delivery. From inception we have delivered novel solutions using our specialized expertise and creative approaches. We support Drug Developers, Health Organizations and Investigators to accelerate the drug development process.
Pre-2020 MRN had been growing at a rate making us one of the fastest growing UK-owned Healthcare firms. MRN had been designed with innovation, process development and recruitment/training systems built to manage high growth rates.
As the pandemic hit, we saw industry-wide clinical trials collapsing and the urgent need to move many into a decentralized model. As we had the processes, systems and personnel to manage significant growth, MRN stepped up to the plate and delivered.
To deliver we recruited, trained and deployed more personnel in 2020 than we had employed 3 years ago. We are managing, despite all of the issues COVID-19 still causes, to successfully complete over 1,600 home trial visits per month. This has been due to our systems, processes and, most of all, the dedication and hard work of our passionate employees and allies who believe in the DCT model as the future of clinical research.
We continue to grow, providing more patients with the opportunity to have access to novel IMP, to participate in clinical research, for studies to recruit and retain more patients in the time allotted, and build for the future.